K008762PAnti-ADO Polyclonal Antibody
- 发布日期: 2020-03-04
- 更新日期: 2026-02-28
产品详请
| 产地 |
北京
|
| 品牌 |
solarbio
|
| 货号 |
K008762P
|
| 保存条件 |
Store at -20°C. Avoid freeze / thaw cycles.
|
| 用途 |
蛋白研究,分析,检测
|
| 应用范围 |
WB
|
| 抗原来源 |
|
| CAS编号 |
|
| 保质期 |
|
| 抗体名 |
Anti-ADO Polyclonal Antibody
|
| 是否单克隆 |
否
|
| 克隆性 |
|
| 靶点 |
ADO
|
| 适应物种 |
Human Mouse
|
| 形态 |
液体
|
| 宿主 |
Rabbit
|
| 标记物 |
|
| 包装规格 |
50ul
|
| 纯度 |
%
|
| 亚型 |
IgG
|
| 标识物 |
|
| 浓度 |
%
|
| 免疫原 |
A synthetic peptide of human ADO
|
| 是否进口 |
否
|
背景资料:Human thiol dioxygenases include cysteine dioxygenase (CDO, MIM 603943) and cysteamine (2-aminoethanethiol) dioxygenase (ADO, EC 1.13.11.19). CDO adds 2 oxygen atoms to free cysteine, whereas ADO adds 2 oxygen atoms to free cysteamine to form hypotaurine. Mouse Ado has strong and specific dioxygenase activity in vitro towards cysteamine but not cysteine. Recombinant Ado was shown to bind iron. Overexpression of Ado in HepG2/C3A cells increased the production of hypotaurine from cysteamine. Similar results were found with human ADO. When endogenous expression of ADO was reduced by RNA-mediated interference, hypotaurine production decreased. The demonstration of high levels of ADO in brain challenges the previous assumption that most of the taurine in the brain is a consequence of CDO activity.